Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Antonio Marra

Research Associate

Sloan Kettering Institute

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (23)

Fausto Maffini

European Institute of Oncology

ITALY

View details

Claudio Bellevicine

Università degli Studi di Napoli Federico II

ITALY

View details

Umberto Malapelle

ITALY

View details

Edoardo Crimini

Medical Oncologist

European Institute of Oncology

ITALY

View details

Katherine Nathanson

Professor

University of Pennsylvania

UNITED STATES

View details

Higinio Dopeso

Senior Research Scientist

Sloan Kettering Institute

UNITED STATES

View details

Caterina Sposetti

Dana-Farber Cancer Institute

UNITED STATES

View details

Lorenzo Ferrando

Assistant Professor

University of Genoa

ITALY

View details

Andrea Vingiani

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Ben O'Leary

Group Leader

Institute of Cancer Research

UNITED KINGDOM

View details

Rania EL BOTTY

Institut Curie

FRANCE

View details

Lisa Anne Carey

Deputy Director for Clinical Science

University of North Carolina at Chapel Hill

UNITED STATES

View details

Gaia Griguolo

University of Padua

ITALY

View details

Giuseppe Curigliano

European Institute of Oncology

ITALY

View details

CARMINE DE ANGELIS

Associate Professor

University of Naples Federico II

ITALY

View details

Rudolf Fehrmann

Tenure track associate professor

University Medical Center Groningen

NETHERLANDS

View details

Luca Boscolo Bielo

European Institute of Oncology

ITALY

View details

Fabio Pagni

University of Milano-Bicocca

ITALY

View details

Giancarlo Troncone

ITALY

View details

David Brown

Sloan Kettering Institute

UNITED STATES

View details

Jia Wu

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Stefania Morganti

Dana-Farber Cancer Institute

UNITED STATES

View details

Nicola Fusco

Director

University of Milan

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Antonio Marra

Research Interests

Make your next move.

Explore related searches

Articles (20)

Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

Harnessing Vaccines in the Treatment of Solid Tumors: Advances, Challenges, and Future Directions

Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study

ESMO basic requirements for AI-based biomarkers in oncology (EBAI)

Design of the Digital Pathology Workspace for Artificial Intelligence Integration

Exploring the immunological effects of antibody–drug conjugates

Oral selective estrogen receptor degraders (SERDs) for the treatment of hormone receptor-positive, HER2-negative breast cancer title

Impact of breast cancer on sexuality and psycho-physical wellbeing: Survey analysis

Conditional Generative AI in Oncology Diagnostics

Tracking response to neoadjuvant systemic therapy through circulating tumor DNA analysis in breast cancer

Corrigendum to: "Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis" [Eur J Cancer 145 (2021) 197-209]

Publisher Correction: APOBEC3 mutagenesis drives therapy resistance in breast cancer

Advancing breast cancer therapy in the era of molecular diagnostics

Artificial Intelligence in Thyroid Cytopathology: Diagnostic and Technical Insights

Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer.

Computational pathology in breast cancer: optimizing molecular prediction through task-oriented AI models

Inter-Assay Variability of TROP2 Immunohistochemistry in Triple-Negative Breast Cancer

Real-world safety and efficacy profiles of trastuzumab deruxtecan in patients with advanced breast cancer

Genomic landscape of breast cancer in elderly patients

Artificial intelligence entering the pathology arena in oncology: current applications and future perspectives

Collaborators (23)

Fausto Maffini

Claudio Bellevicine

Umberto Malapelle

Edoardo Crimini

Katherine Nathanson

Higinio Dopeso

Caterina Sposetti

Lorenzo Ferrando

Andrea Vingiani

Ben O'Leary

Rania EL BOTTY

Lisa Anne Carey

Gaia Griguolo

Giuseppe Curigliano

CARMINE DE ANGELIS

Rudolf Fehrmann

Luca Boscolo Bielo

Fabio Pagni

Giancarlo Troncone

David Brown

Jia Wu

Stefania Morganti

Nicola Fusco

Make your next move.